Literature DB >> 12672247

Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency.

Raymond J Bergeron1, Jan Wiegand, James S McManis, Jörg Bussenius, Richard E Smith, William R Weimar.   

Abstract

The impact of altering the octanol-water partition properties (log P) of analogues of desazadesferrithiocin, (S)-4,5-dihydro-2-(2-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid, on the ligands' iron clearing properties is described. Increasing chelator lipophilicity can both substantially augment iron clearing efficiency in Cebus apella primates as well as alter the mode of iron excretion, favoring fecal over urinary output. The complications of iron overload are often associated with the metal's interaction with hydrogen peroxide, generating hydroxyl radicals (Fenton chemistry) and, ultimately, other related deleterious species. In fact, some iron chelators actually promote this chemistry. All of the compounds synthesized and tested in the current study are shown to be both inhibitors of the iron-mediated oxidation of ascorbate, thus removing the metal from the Fenton cycle, and effective radical scavengers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672247     DOI: 10.1021/jm020412d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.

Authors:  Raymond J Bergeron; Neelam Bharti; Jan Wiegand; James S McManis; Shailendra Singh; Khalil A Abboud
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

2.  The design, synthesis, and evaluation of organ-specific iron chelators.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti
Journal:  J Med Chem       Date:  2006-11-30       Impact factor: 7.446

3.  Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators.

Authors:  Raymond J Bergeron; Shailendra Singh; Neelam Bharti; Yi Jiang
Journal:  Synthesis (Stuttg)       Date:  2010       Impact factor: 3.157

4.  (S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; John R T Vinson; Hua Yao; Neelam Bharti; James R Rocca
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

5.  Transdermal deferoxamine prevents pressure-induced diabetic ulcers.

Authors:  Dominik Duscher; Evgenios Neofytou; Victor W Wong; Zeshaan N Maan; Robert C Rennert; Mohammed Inayathullah; Michael Januszyk; Melanie Rodrigues; Andrey V Malkovskiy; Arnetha J Whitmore; Graham G Walmsley; Michael G Galvez; Alexander J Whittam; Michael Brownlee; Jayakumar Rajadas; Geoffrey C Gurtner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

6.  Desferrithiocin analogues and nephrotoxicity.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti; Shailendra Singh
Journal:  J Med Chem       Date:  2008-09-13       Impact factor: 7.446

7.  Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.

Authors:  Raymond J Bergeron; Jan Wiegand; Neelam Bharti; James S McManis
Journal:  J Med Chem       Date:  2012-08-13       Impact factor: 7.446

8.  Desferrithiocin analogue uranium decorporation agents.

Authors:  Raymond J Bergeron; Jan Wiegand; Shailendra Singh
Journal:  Int J Radiat Biol       Date:  2009-04       Impact factor: 2.694

9.  Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti; Shailendra Singh
Journal:  J Med Chem       Date:  2008-06-06       Impact factor: 7.446

10.  Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.

Authors:  Raymond J Bergeron; Jan Wiegand; Neelam Bharti; Shailendra Singh; James R Rocca
Journal:  J Med Chem       Date:  2007-06-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.